$4.34 Billion is the total value of RTW INVESTMENTS, LP's 86 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DNAY | Exit | CODEX DNA INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| Exit | MINERVA SURGICAL INC | $0 | – | -166,000 | -100.0% | -0.01% | – | |
| OMIC | Exit | SINGULAR GENOMICS SYSTEMS IN | $0 | – | -100,000 | -100.0% | -0.01% | – |
| RCEL | Exit | AVITA MEDICAL INC | $0 | – | -106,667 | -100.0% | -0.01% | – |
| Exit | ISOPLEXIS CORP | $0 | – | -365,000 | -100.0% | -0.02% | – | |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -258,064 | -100.0% | -0.02% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -682,220 | -100.0% | -0.04% | – | |
| GTH | Exit | GENETRON HLDGS LTDads | $0 | – | -1,198,961 | -100.0% | -0.05% | – |
| Exit | RXSIGHT INC | $0 | – | -150,000 | -100.0% | -0.06% | – | |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -471,630 | -100.0% | -0.07% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -1,583,822 | -100.0% | -0.08% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -490,000 | -100.0% | -0.09% | – |
| Exit | MAXCYTE INC | $0 | – | -772,735 | -100.0% | -0.09% | – | |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -2,849,707 | -100.0% | -0.14% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -161,138 | -100.0% | -0.14% | – | |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -2,327,403 | -100.0% | -0.19% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -270,000 | -100.0% | -0.24% | – |
| Exit | SOMALOGIC INC | $0 | – | -2,114,830 | -100.0% | -0.25% | – | |
| CDXS | Exit | CODEXIS INC | $0 | – | -920,448 | -100.0% | -0.25% | – |
| Exit | CYTEK BIOSCIENCES INC | $0 | – | -916,838 | -100.0% | -0.25% | – | |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -42,000 | -100.0% | -0.26% | – |
| CYRX | Exit | CRYOPORT INC | $0 | – | -335,299 | -100.0% | -0.27% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -3,975,554 | -100.0% | -0.30% | – |
| VERU | Exit | VERU INC | $0 | – | -2,220,983 | -100.0% | -0.65% | – |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -1,819,120 | -100.0% | -0.76% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.